Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing-Reference-Cited by-同舟云学术

Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typing

Published:1993-05 Issue:1 Volume:84 Page:61-66
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ljungman Per,Witte Theo,Verdonck Leo,Gahrton Gösta,Freycon Fernand,Gravett Peter,McCann Shaun,Morgenstern H. G.,Nikoskelainen Jukka,Powles Ray,Proctor Steven J.,Volin Liisa,Zwaan Ferry,Gratwohl Alois

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1993.tb03025.x/fullpdf

Reference13 articles.

1. Bone Marrow Transplantation or Chemotherapy After Remission Induction for Adults with Acute Nonlymphoblastic Leukemia

2. Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up

3. CHEMOTHERAPY VERSUS TRANSPLANTATION IN ACUTE LEUKAEMIA

4. AUTOTRANSPLANTS IN LEUKAEMIA

5. Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Intensity transplantation vs chemotherapy in CR1. A prospective, pseudorandomized study in 50–70 year old AML patients;Bone Marrow Transplantation;2024-09-02

2. False Homozygosity Results in HLA Genotyping due to Loss of Chromosome 6 in a Patient with Acute Lymphoblastic Leukemia;Annals of Laboratory Medicine;2011-10-01

3. Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia;European Journal of Haematology;2009-04-24

4. CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT;Bone Marrow Transplantation;2009-01-12

5. Use of biological assignment in hematopoietic stem cell transplantation clinical trials;Clinical Trials;2008-12